Barry Herman, MD, MMM

Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in the Treatment of Children With Attention-Deficit/Hyperactivity Disorder

Objective: Determine if AMPH EROS has an onset of effect at 30 minutes post-dose in children with ADHD.

Antonio Pardo , MD;

Barry Herman , MD, MMM;

Ann Childress , MD;

Thomas King , MS, MPH;

11/22/2019

Single-Dose Pharmacokinetics of Amphetamine Extended-Release Tablet (AMPH ER TAB) Compared With Amphetamine Extended-Release Oral Suspension (AMPH EROS)

OBJECTIVES: Evaluate bioavailability of single-dose amphetamine extended-release tablet (AMPH ER TAB) 20 mg, swallowed whole/chewed and amphetamine extended-release oral suspension (AMPH ...

Thomas King , MS, MPH;

Antonio Pardo , MD;

Barry Herman , MD, MMM;

11/22/2019

Featured CME

The Medication Access and Training Expansion (MATE) Act requires prescribers renewing their DEA registration to have completed at least 8 hours of training on opioid or other substance use disorders.

Upcoming Events

April 3 ⁠–⁠ April 4

April 5 ⁠–⁠ April 6

April 21 ⁠–⁠ April 24

April 29 ⁠–⁠ April 30

April 30 ⁠–⁠ May 4

May 1 ⁠–⁠ May 2

May 7 ⁠–⁠ May 9

May 8 ⁠–⁠ May 10

May 14 ⁠–⁠ May 16

May 19 ⁠–⁠ May 21

See Full Calendar

Barry Herman, MD, MMM

Featured CME

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products